Hyundai Mobis Co. has come up with an in-house brainwave-based driver monitoring system that can reduce the risk of drowsy driving by up to one-third.
The system, dubbed M.Brain, is a wearable earpiece that continuously detects and analyzes drivers' brain activity.
The company has examined the actual effect of the technology through a pilot study on public buses in Gyeonggi Province over the past year in partnership with the Gyeonggi Research Institute.
According to the findings, drivers who used M.Brain saw their risk of careless driving during after-meal hours, when drowsy driving is most common, drop by up to 30 percent.
M.Brain helped minimize the danger of careless driving by roughly 20% on highways where drowsy driving can lead to multi-car accidents.
When sloppy driving was detected in real-time, the device helped drivers recover attention within 2.3 seconds by blasting an alarm over the speakers and vibrating the seat.
This is nearly three times faster than the 6.7 seconds it took non-M.Brain drivers to regain attention.


FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
Rio Tinto Signs Interim Agreement With Yinhawangka Aboriginal Group Over Pilbara Mining Operations
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Nvidia Develops New Location-Verification Technology for AI Chips
Microsoft Unveils Massive Global AI Investments, Prioritizing India’s Rapidly Growing Digital Market
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Samsung SDI Secures Major LFP Battery Supply Deal in the U.S.
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk
Neuralink Expands Brain Implant Trials with 12 Global Patients 



